These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24827397)

  • 1. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
    Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
    Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
    Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
    Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
    Chang HJ; Kim SW; Kim YT; Kim WH
    Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
    Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
    Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
    Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
    J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.
    Maitra A; Wistuba II; Washington C; Virmani AK; Ashfaq R; Milchgrub S; Gazdar AF; Minna JD
    Am J Pathol; 2001 Jul; 159(1):119-30. PubMed ID: 11438460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
    Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
    Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma.
    Kim YT; Kim J; Jang YH; Lee WJ; Ryu JK; Park YK; Kim SW; Kim WH; Yoon YB; Kim CY
    Cancer Lett; 2001 Aug; 169(1):59-68. PubMed ID: 11410326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in gallbladder carcinoma.
    Kuroki T; Tajima Y; Matsuo K; Kanematsu T
    Surg Today; 2005; 35(2):101-5. PubMed ID: 15674488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol Gallstones Larger Than 3 cm Appear to Be Associated With Gallbladder Cancer: Identification of a High Risk Group of Patients That Could Benefit From Preventive Cholecystectomy.
    Andrea C; Enzo A
    Ann Surg; 2016 Mar; 263(3):e56. PubMed ID: 25793627
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
    Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
    Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
    Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
    Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of chromosome 16q in gallbladder carcinoma.
    Matsuo K; Kuroki T; Kitaoka F; Tajima Y; Kanematsu T
    J Surg Res; 2002 Feb; 102(2):133-6. PubMed ID: 11796009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions. Prognostic implications.
    Sanz-Ortega J; Sanz-Esponera J; Caldes T; Gomez de la Concha E; Sobel ME; Merino MJ
    Pathol Res Pract; 1996 Dec; 192(12):1206-10. PubMed ID: 9182290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation.
    Sanz-Ortega J; Valor C; Saez MC; Ortega L; Sierra E; Poch J; Hernández S; Sanz-Esponera J
    Histol Histopathol; 2003 Oct; 18(4):1053-7. PubMed ID: 12973674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
    Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
    Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.